Cellarity is the older company (2017 vs 2020); Cellarity is the larger of the two.
Side-by-Side Comparison
| Metric | Cellarity | MTHERA PHARMA |
|---|---|---|
| Founded | ||
| Founded | 2017 older | 2020 |
| Headquarters | ||
| Headquarters | Somerville, United States | Seoul, Korea South |
| Employees | ||
| Employees | 76 larger | 8 |
| Industry | ||
| Industry | Biotechnology, Life Sciences, Pharmaceutical | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series C | Series Unknown |
| Total Funding | ||
| Total Funding | $294.00M | $3.50B |
| Funding Rounds | ||
| Funding Rounds | 3 | 6 |
| Services | ||
| Services | Cell State-Correcting Therapeutics, AI-Powered Drug Discovery Platform, Mapping Cellular Interactions | Not tracked yet |
| Target Customers | ||
| Target Customers | Biopharmaceutical Companies, Healthcare Researchers, Medical Professionals, Patients with Complex Diseases | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Drug Discovery, Drug Development, Cellular Dysfunction, AI Models, Single Cell Transcriptomes, Metabolic Disease, Hematology, Immuno-oncology, Genomic Technologies, Proprietary Platforms, Systems Biology, Therapeutics, Non-intuitive Drug Candidates, Cellular And Molecular Complexity | Biopharmaceutical, Drug Development, Multi-target Therapy, SyMthomics Platform, AI-based In Silico System, Multi-omics Integration, Systems Biology, Bioinformatics, Standardization Technology, CMC Technology, Botanical Drug Products, Therapeutic Consistency, Parkinson's Disease, Inflammatory Bowel Disease, FDA Requirements |
| Website | ||
| Website | cellarity.com | mtherapharma.com |
About Cellarity
Cellarity, launched by Flagship Pioneering in 2017, is a pioneering force in the biotechnology sector. Their slogan, "Rewriting the rules of drug creation," reflects their groundbreaking approach to pharmaceutical innovation by addressing cellular dysfunction rather than focusing on single targets....
About MTHERA PHARMA
MThera Pharma Co., Ltd. is a biopharmaceutical company founded in 2020 in South Korea. The company is focused on developing novel multi-component/multi-target driven, disease-modifying therapies for chronic incurable diseases. MThera has established the platform technology, SyMthomics, which consist...
We will tell you when either one moves
BounceWatch watches Cellarity and MTHERA PHARMA for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Cellarity and MTHERA PHARMA — by email.
Frequently Asked Questions
Compare Cellarity with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Cellarity on 15 Jun 2026, and MTHERA PHARMA on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.